Clover Corporation Limited (ASX:CLV)

Market Cap	113.56M
Revenue (ttm)	86.00M
Net Income (ttm)	7.02M
Shares Out	167.00M
EPS (ttm)	0.04
PE Ratio	16.19
Forward PE	14.45
Dividend	0.02 (2.92%)
Ex-Dividend Date	Oct 20, 2025

Volume	11,059
Average Volume	307,058
Open	0.6900
Previous Close	0.6850
Day's Range	0.6800 - 0.7000
52-Week Range	0.3370 - 0.7450
Beta	0.07
RSI	60.85
Earnings Date	Sep 23, 2025

About Clover Corporation

Clover Corporation Limited engages in the production, refining, and sale of natural oils and encapsulated powders in Australia, New Zealand, Asia, Europe, the Middle East, and the Americas. It supplies refined Omega 3 oils and various encapsulated ingredients for infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. The company offers Nu-Mega’s Driphorm microencapsulated powders, which enables the addition of Hi-DHA tuna and/or algal oils to products. Clover Corporation Limited was incorporated in 1988 and is headquarte...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1988
• Employees: 68
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CLV

Financial Performance

In 2025, Clover Corporation's revenue was 86.00 million, an increase of 38.25% compared to the previous year's 62.21 million. Earnings were 7.02 million, an increase of 382.46%.